Avodart Ad Misleading
Avodart Misleading Advertisements. Another drug marketing campaign has federal regulators concerned about misleading advertisements. GlaxoSmithKline’s prostate drug, Avodart’s, TV ads utilize a space theme that has been criticized by the U.S. Food and Drug Administration (FDA), reports the Star Tribune. Avodart is prescribed to … [Read more...] about Avodart Ad Misleading
FDA Criticizes Cymbalta’s Medical Journal Ads
Cymbalta Medical Journal Ads Has Been Scrutinized. Eli Lilly & Co. failed to make the risks of its Cymbalta medicine clear enough in medical journal advertisements that promoted the drug to treat nerve pain caused by diabetes, U.S. regulators said. In a letter to Lilly posted Wednesday on the U.S. Food and Drug … [Read more...] about FDA Criticizes Cymbalta’s Medical Journal Ads
